$13.89
0.64[4.83%]
At close: Apr 26
$13.89
0[0.00%]
After Hours: 6:54PM EDT
Teva Pharmaceutical Indus
(NYSE:TEVA)Teva Pharmaceutical Indus Stock (NYSE:TEVA), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/31/2024 | TEVA | Teva Pharmaceutical Indus | FY | 2024 | $2.20 | $2.50 | $2.42 | $15.70B | $16.30B | $15.57B | Get Alert |
| 11/08/2023 | TEVA | Teva Pharmaceutical Indus | FY | 2023 | $2.25 | $2.55 | $2.28 | $15.10B | $15.50B | $15.14B | Get Alert |
| 08/02/2023 | TEVA | Teva Pharmaceutical Indus | FY | 2023 | $2.25 | $2.55 | $2.27 | $15.00B | $15.40B | $15.02B | Get Alert |
| 05/10/2023 | TEVA | Teva Pharmaceutical Indus | FY | 2023 | $2.25 | $2.55 | $2.40 | $14.80B | $15.40B | $15.06B | Get Alert |
| 02/08/2023 | TEVA | Teva Pharmaceutical Indus | FY | 2023 | $2.25 | $2.55 | $2.52 | $14.80B | $15.40B | $15.23B | Get Alert |
| 11/03/2022 | TEVA | Teva Pharmaceutical Indus | FY | 2022 | $2.40 | $2.60 | $2.50 | $14.80B | $15.40B | $15.46B | Get Alert |
| 07/26/2022 | TEVA | Teva Pharmaceutical Indus | FY | 2022 | $2.40 | $2.60 | — | $15.00B | $15.60B | $15.67B | Get Alert |
| 05/03/2022 | TEVA | Teva Pharmaceutical Indus | FY | 2022 | $2.40 | $2.60 | $2.51 | $15.40B | $16.00B | $15.97B | Get Alert |
| 02/09/2022 | TEVA | Teva Pharmaceutical Indus | FY | 2022 | $2.40 | $2.60 | $2.64 | $15.60B | $16.20B | $16.32B | Get Alert |
| 10/27/2021 | TEVA | Teva Pharmaceutical Indus | FY | 2021 | $2.50 | $2.70 | $2.58 | $16.00B | $16.40B | $16.30B | Get Alert |
| 07/28/2021 | TEVA | Teva Pharmaceutical Indus | FY | 2021 | $2.50 | $2.70 | $2.45 | $16.00B | $16.40B | $16.55B | Get Alert |
| 04/28/2021 | TEVA | Teva Pharmaceutical Indus | FY | 2021 | $2.50 | $2.70 | $2.61 | $16.40B | $16.80B | $16.68B | Get Alert |
| 02/10/2021 | TEVA | Teva Pharmaceutical Indus | FY | 2021 | $2.50 | $2.70 | $2.63 | $16.40B | $16.80B | $16.76B | Get Alert |
| 11/05/2020 | TEVA | Teva Pharmaceutical Indus | FY | 2020 | $2.40 | $2.55 | $2.51 | $16.50B | $16.80B | $16.69B | Get Alert |
| 08/05/2020 | TEVA | Teva Pharmaceutical Indus | FY | 2020 | $2.30 | $2.55 | $2.50 | $16.60B | $17.00B | $16.80B | Get Alert |
| 05/07/2020 | TEVA | Teva Pharmaceutical Indus | FY | 2020 | $2.30 | $2.55 | $2.44 | $16.60B | $17.00B | $16.70B | Get Alert |
| 02/12/2020 | TEVA | Teva Pharmaceutical Indus | FY | 2020 | $2.30 | $2.55 | $2.47 | $16.60B | $17.00B | $17.18B | Get Alert |
| 11/07/2019 | TEVA | Teva Pharmaceutical Indus | FY | 2019 | $2.30 | $2.50 | $2.38 | $17.20B | $17.40B | $17.18B | Get Alert |
FAQ
What is the most recent guidance for Teva Pharmaceutical Indus (TEVA)?
The last reported Earnings numbers were from January 31, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $2.20 and $2.50 versus the estimated EPS of $2.42.
Browse guidance and forecast on all stocks.